Carr Douglas
SEC CIK 1867173 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| IPSC | Century Therapeutics, Inc. | VP Fin, Ops | 502.9K | — | $39.8K | 29 | 2023-02-02 | 2026-09-14 |
Most active insiders at IPSC, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Pfeiffenberger Brent | Pres, CEO, Dir | $47.7K | $14.6K |
| 2 | Cowan Chad | CSO | $49.4K | $2,731 |
| 3 | Russotti Gregory | See Remarks | — | $40.2K |
| 4 | Carr Douglas | SVP Fin, Ops | — | $28.6K |
Transactions 29
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-09-15 18:25 | 2026-09-14 | IPSC | Century Therapeutics, Inc. | Carr Douglas | SVP Fin, Ops | S - Sale | $1.93 | -1,658 | 502.9K | -0.3% | -$3,200 | |
| 2026-09-09 16:34 | 2026-09-08 | IPSC | Century Therapeutics, Inc. | Carr Douglas | SVP Fin, Ops | S - Sale | $2.05 | -254 | 504.6K | -0.1% | -$520.70 | |
| 2026-08-05 16:08 | 2026-08-03 | IPSC | Century Therapeutics, Inc. | Carr Douglas | SVP Fin, Ops | S - Sale | $1.98 | -275 | 504.8K | -0.1% | -$543.68 | |
| 2026-06-15 19:56 | 2026-06-12 | IPSC | Century Therapeutics, Inc. | Carr Douglas | SVP Fin, Ops | S - Sale | $2.23 | -1,654 | 505.1K | -0.3% | -$3,692 | |
| 2026-06-09 16:10 | 2026-06-08 | IPSC | Century Therapeutics, Inc. | Carr Douglas | SVP Fin, Ops | S - Sale | $2.11 | -249 | 506.7K | -0.0% | -$525.64 | |
| 2026-05-06 17:27 | 2026-05-04 | IPSC | Century Therapeutics, Inc. | Carr Douglas | SVP Fin, Ops | S - Sale | $2.34 | -264 | 507.0K | -0.1% | -$618.02 | |
| 2026-03-16 | 2026-03-12 | IPSC | Century Therapeutics, Inc. | Carr Douglas | SVP Fin, Ops | S - Sale | $2.55 | -7,043 | 507.3K | -1% | -$18.0K | |
| 2026-03-11 | 2026-03-09 | IPSC | Century Therapeutics, Inc. | Carr Douglas | SVP Fin, Ops | S - Sale | $2.54 | -247 | 514.3K | -0.0% | -$627.38 | |
| 2026-02-05 | 2026-02-03 | IPSC | Century Therapeutics, Inc. | Carr Douglas | SVP Fin, Ops | S - Sale | $1.82 | -323 | 514.6K | -0.1% | -$587.86 | |
| D | 2026-02-04 | 2026-02-02 | IPSC | Century Therapeutics, Inc. | Carr Douglas | SVP Fin, Ops | A - Grant | $0.00 | +110.0K | 514.9K | +27% | $0 |
| 2025-12-10 | 2025-12-08 | IPSC | Century Therapeutics, Inc. | Carr Douglas | SVP Fin, Ops | S - Sale | $0.53 | -257 | 404.9K | -0.1% | -$136.21 | |
| 2025-11-05 | 2025-11-03 | IPSC | Century Therapeutics, Inc. | Carr Douglas | SVP Fin, Ops | S - Sale | $0.59 | -292 | 405.1K | -0.1% | -$172.28 | |
| 2025-09-10 | 2025-09-08 | IPSC | Century Therapeutics, Inc. | Carr Douglas | SVP Fin, Ops | S - Sale | $0.5 | -263 | 405.4K | -0.1% | -$131.50 | |
| 2025-08-06 | 2025-08-04 | IPSC | Century Therapeutics, Inc. | Carr Douglas | SVP Fin, Ops | S - Sale | $0.53 | -296 | 405.7K | -0.1% | -$156.88 | |
| 2025-06-11 | 2025-06-09 | IPSC | Century Therapeutics, Inc. | Carr Douglas | SVP Fin, Ops | S - Sale | $0.62 | -4,904 | 406.0K | -1% | -$3,040 | |
| 2025-05-07 | 2025-05-05 | IPSC | Century Therapeutics, Inc. | Carr Douglas | SVP Fin, Ops | S - Sale | $0.55 | -295 | 410.9K | -0.1% | -$162.25 | |
| D | 2025-03-12 | 2025-03-11 | IPSC | Century Therapeutics, Inc. | Carr Douglas | SVP Fin, Ops | A - Grant | $0.00 | +95.6K | 411.2K | +30% | $0 |
| D | 2025-03-12 | 2025-03-10 | IPSC | Century Therapeutics, Inc. | Carr Douglas | SVP Fin, Ops | S - Sale | $0.62 | -1,240 | 315.6K | -0.4% | -$768.80 |
| 2025-02-05 | 2025-02-03 | IPSC | Century Therapeutics, Inc. | Carr Douglas | SVP Fin, Ops | S - Sale | $0.78 | -351 | 316.8K | -0.1% | -$273.78 | |
| 2024-11-05 | 2024-11-04 | IPSC | Century Therapeutics, Inc. | Carr Douglas | SVP Fin, Ops | S - Sale | $1.23 | -283 | 317.1K | -0.1% | -$348.09 | |
| 2024-11-05 | 2024-11-01 | IPSC | Century Therapeutics, Inc. | Carr Douglas | SVP Fin, Ops | F - Tax | $1.26 | -16.6K | 317.4K | -5% | -$20.9K | |
| 2024-08-07 | 2024-08-05 | IPSC | Century Therapeutics, Inc. | Carr Douglas | SVP Fin, Ops | S - Sale | $1.83 | -289 | 334.0K | -0.1% | -$528.87 | |
| 2024-06-10 | 2024-06-07 | IPSC | Century Therapeutics, Inc. | Carr Douglas | SVP Fin, Ops | A - Grant | $0.00 | +17.0K | 334.3K | +5% | $0 | |
| 2024-05-07 | 2024-05-03 | IPSC | Century Therapeutics, Inc. | Carr Douglas | SVP Fin, Ops | S - Sale | $3.11 | -257 | 317.3K | -0.1% | -$799.27 | |
| D | 2024-03-11 | 2024-03-07 | IPSC | Century Therapeutics, Inc. | Carr Douglas | SVP Fin, Ops | A - Grant | $0.00 | +14.0K | 317.6K | +5% | $0 |
| M | 2024-02-07 | 2024-02-05+ | IPSC | Century Therapeutics, Inc. | Carr Douglas | SVP Fin, Ops | S - Sale | $4.14 | -1,200 | 304.1K | -0.4% | -$4,970 |
| 2023-11-03 | 2023-11-01 | IPSC | Century Therapeutics, Inc. | Carr Douglas | SVP Fin, Ops | F - Tax | $1.49 | -16.6K | 304.8K | -5% | -$24.8K | |
| 2023-05-17 | 2023-05-15 | IPSC | Century Therapeutics, Inc. | Carr Douglas | SVP Fin, Ops | A - Grant | $0.00 | +120.8K | 321.4K | +60% | $0 | |
| DM | 2023-02-06 | 2023-02-02 | IPSC | Century Therapeutics, Inc. | Carr Douglas | VP Fin, Ops | A - Grant | $0.00 | +15.0K | 193.0K | +8% | $0 |
Purchase Sale Sale after option exercise All abbreviations